Dumac, Inc.
- SEC CIK
- 0001584258
- Latest filing
- Aug 11, 2026
SGMT holding history
Sagimet Biosciences Inc. in every 13F filed by Dumac, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMT overviewAll 13F holders of SGMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 71,192
- Value
- $550.3K
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 71,192 | $550.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 71,192 | $372.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 71,192 | $421.5K | 0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 75,000 | $571.5K | 3.6% | −72,351−49.1% | Reduced | Holders |
| Q1 2025 | 147,351 | $480.4K | 1.9% | −16,163−9.9% | Reduced | Holders |
| Q4 2024 | 163,514 | $735.8K | 1.1% | −25,880−13.7% | Reduced | Holders |
| Q3 2024 | 189,394 | $524.6K | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 189,394 | $647.7K | 2.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 189,394 | $1.03M | 3.7% | −14,729−7.2% | Reduced | Holders |
| Q4 2023 | 204,123 | $1.11M | 3.4% | 00.0% | Unchanged | Holders |
| Q3 2023 | 204,123 | $1.80M | 4.8% | +204,123 | New | Holders |